Flow Cytometry Market Research Report Information Forecast to 2032
The Flow Cytometry Market is expected to register a healthy CAGR of 7.47% during the forecast period.
The elements that are driving the development of the worldwide market are the rising pervasiveness of ongoing infections and developing interest for purpose in care testing.
There has been a critical expansion in the pervasiveness of ongoing sicknesses like malignant growth, cardiovascular illnesses, immune system infections, irresistible sicknesses, and others which has prompted an expanded interest for cutting edge symptomatic and research devices, for example, flow cytometry. For example, as per World Wellbeing Association (WHO) figures, malignant growth is the essential or second driving reason for death in 112 of 183 countries before the age of 70. Likewise, GLOBOCAN 2020 assessments of disease frequency delivered by the Global Organization for Research on Malignant growth state around the world, an expected 19.3 million new disease cases in 2020.
Besides, the rising interest for purpose in care testing (POCT) has been a significant driver of the flow cytometry market. POCT alludes to indicative testing performed at or close to the patient's area, giving quick and prompt outcomes. In this specific circumstance, flow cytometry has acquired conspicuousness because of its capacity to convey continuous, high-throughput examination of individual cells, making it a significant device for decentralized demonstrative settings.
Market SegmentationThe Flow Cytometry Market is divided into five segments based on components: software, services, reagents and consumables, accessories, cytometry platforms, and others. Additionally, the cytometry platform has been divided into two sections: cell sorters and cell analyzers; accessories, further divided into filter, laser, detectors, and other categories; and reagents and consumables, further divided into categories such as antibodies, dyes, beads, solution, buffer, and other categories. Based on technology the market is divided into bead-based flow cytometry and cell-based flow cytometry. The flow cytometry market is divided into two segments based on application: diagnosis applications and applications for academic and clinical research. Based on the end user, the market is divided into hospitals and clinics, businesses, clinical labs and medical schools, research institutes, and others.
Regional InsightsNorth America is likely to lead the market with high sending of logically progressed flow cytometry advancements, huge medical care spending, and deeply grounded medical services foundation in the region.
Europe flow cytometry market shows critical development during the figure year, i.e., 2022-2023, attributable to the rising ongoing sickness commonness, expanding need for new advances in the flow cytometry industry, which builds request, and rising interest in research and improvement, which prompts market extension.
The Asia-Pacific flow cytometry market is the fastest developing region because of the extending drug and biotechnology enterprises in rising economies like China and India. China's rising research commitments are because of the pattern of cytometry science and innovation being an outskirts multidisciplinary research subject, drawing in a great deal of research consideration from both scholarly world and industry. Also, in Australia, research and improvement drives keep on developing.
Major PlayersMajor Players in the Flow Cytometry Market are Cytek Biosciences, Inc. (US), Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Beckman Coulter, Inc. (US), Sartorius AG (Germany), Bio-Rad Laboratories, Inc. (US), Becton, Miltenyi Biotec (Germany), Sysmex Corporation (Japan), Dickinson, and Company (US), and Luminex Corporation (US).
Companies MentionedThermo Fisher Scientific Inc. (US)
Beckman Coulter Inc. (US)
Becton
Dickinson
and Company (US)
Agilent Technologies Inc. (US)
Sartorius AG (Germany)
Miltenyi Biotec (Germany)
Cytek Biosciences Inc. (US)
Sysmex Corporation (Japan)
Bio-Rad Laboratories Inc. (US)
and Luminex Corporation (US).